Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Programs for Continuing Medical Education: A session; 6. Advances in basic research and therapy of multiple sclerosis].
Advances in the management of MS symptoms: recently proposed clinical management algorithms.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
Functional Assessment of Multiple Sclerosis.
Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.
Regulatory effect of triiodothyronine on brain myelination and astrogliosis after cuprizone-induced demyelination in mice.
Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes.
Association between chronic stress-induced structural abnormalities in Ranvier nodes and reduced oligodendrocyte activity in major depression.
[The possibility of using music therapy in neurology on the example of multiple sclerosis].
Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components?
Pregnancy in multiple sclerosis.
Multiple Sclerosis and Experimental Allergic Encephalomyelitis.
Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis.
Pediatric demyelinating diseases.
Dimethyl Fumarate Modulation of Immune and Antioxidant Responses: Application to HIV Therapy.
A polymorphism in the resistin gene promoter and the risk of multiple sclerosis.
Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders.
Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.
Bladder management in multiple sclerosis.
Higher Circulating Levels of Chemokine CCL20 in Patients with Multiple Sclerosis: Evaluation of the Influences of Chemokine Gene Polymorphism, Gender, Treatment and Disease Pattern.
Inflammatory demyelinating central nervous system diseases in childhood: clinical and paraclinical profiles in 133 patients.
First case report of acute hemorrhagic leukoencephalitis following Plasmodium vivax infection.
Fibronectin in tissue regeneration: timely disassembly of the scaffold is necessary to complete the build.
Assessment of the Effect of Cigarette Smoking on Regional Brain Volumes and Lesion Load in Patients with Clinically Isolated Syndrome.
Gamma-aminobutyric acid receptor agonists, aquaporin-4, and neuromyelitis optica: a potential link.
Pages
« first
‹ previous
…
580
581
582
583
584
585
586
587
588
…
next ›
last »